Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Syndecan 4 ELISA Kit (AC3717)
Cat.#: ASET-2306
Specifications
Description Human Syndecan 4 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Syndecan 4 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.053 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1958 Human P311 ELISA Kit (AC3369) Quantitative inquiry ASET-1205 Rat PON2 ELISA Kit (AC2616) Quantitative inquiry ASET-2537 Human Neurofilament Heavy Polypeptide ELISA Kit (AC3948) Quantitative inquiry ASET-1113 Human MAdCAM1 ELISA Kit (AC2524) Quantitative inquiry ASET-1266 Mouse Cathepsin D ELISA Kit (AC2677) Quantitative inquiry ASET-1287 Rat Creatine Kinase B Type ELISA Kit (AC2698) Quantitative inquiry ASET-2454 Human LAR ELISA Kit (AC3865) Quantitative inquiry ASET-2486 Human Doublecortin ELISA Kit (AC3897) Quantitative inquiry ASET-2355 Mouse Kisspeptin ELISA Kit (AC3766) Quantitative inquiry ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket